Selective Inhibition of Bruton’s Tyrosine Kinase by a Designed Covalent Ligand Leads to Potent Therapeutic Efficacy in Blood Cancers Relative to Clinically Used Inhibitors

1. Sousa, B.B.
2. de Almeida, C.R.
3. Barahona, A.F.
4. Lopes, R.
5. Martins-Logrado, A.
6. Cavaco, M.
7. Neves, V.
8. Carvalho, L.A.R.
9. Labaõ-Almeida, C.
10. Coelho, A.R.
11. Bento, M.L.
12. Lopes, R.M.R.M.
13. Oliveira, B.L.
14. Castanho, M.A.R.B.
15. Neumeister, P.
16. Deutsch, A.
17. Vladimer, G.I.
18. Krall, N.
19. Joaõ, C.
20. Corzana, F.
21. Seixas, J.D.
22. Fior, R.
23. Bernardes, G.J.L.